Latest filing published 03 Oct 2014 for Raptor Pharmaceutical Corp, €51k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Trading Segregated Portfolio Hyperion: trading record in brief
This profile gathers the share dealings of Trading Segregated Portfolio Hyperion in Raptor Pharmaceutical Corp. The record holds 94 filings, for trades running from 8 May 2012 to 23 August 2013.
Market trades split into 46 purchases (€8.2M) and 48 sales (€17.6M). The net balance comes to €9.4M on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2014 alone, the filings show 46 purchases and 48 sales.
A typical purchase (the median) is worth €128k.
On 3 October 2014 came the latest disclosure, an open-market purchase for €51k in Raptor Pharmaceutical Corp. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Trading Segregated Portfolio Hyperion
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 11,500 shares@ US$5.89Common Stock, par value $0.001 per shareSEC:0000905718-14-000645:0Canonical exit: 2 Apr 2013 (T+90)
- 7,182 shares@ US$5.98Common Stock, par value $0.001 per shareSEC:0000905718-14-000645:1
- 5,568 shares@ US$6.06Common Stock, par value $0.001 per shareSEC:0000905718-14-000645:2
- 4,700 shares@ US$6.10Common Stock, par value $0.001 per shareSEC:0000905718-14-000645:3
- 1,800 shares@ US$6.26Common Stock, par value $0.001 per shareSEC:0000905718-14-000645:4
- 21,800 shares@ US$6.16Common Stock, par value $0.001 per shareSEC:0000905718-14-000645:5Canonical exit: 7 Apr 2013 (T+90)
- 23,977 shares@ US$6.19Common Stock, par value $0.001 per shareSEC:0000905718-14-000645:6Canonical exit: 8 Apr 2013 (T+90)
- 56,352 shares@ US$6.13Common Stock, par value $0.001 per shareSEC:0000905718-14-000645:7Canonical exit: 9 Apr 2013 (T+90)
- 4,400 shares@ US$5.91Common Stock, par value $0.001 per shareSEC:0000905718-14-000645:8
- 2,000 shares@ US$5.75Common Stock, par value $0.001 per shareSEC:0000905718-14-000645:9Canonical exit: 16 Apr 2013 (T+90)
- 7,000 shares@ US$5.75Common Stock, par value $0.001 per shareSEC:0000905718-14-000645:10Canonical exit: 17 Apr 2013 (T+90)
- 3,000 shares@ US$5.70Common Stock, par value $0.001 per shareSEC:0000905718-14-000645:11Canonical exit: 22 Apr 2013 (T+90)
- 24,500 shares@ US$5.45Common Stock, par value $0.001 per shareSEC:0000905718-14-000645:12Canonical exit: 28 Apr 2013 (T+90)
- 98,818 shares@ US$5.42Common Stock, par value $0.001 per shareSEC:0000905718-14-000645:13Canonical exit: 29 Apr 2013 (T+90)
- 69,455 shares@ US$5.41Common Stock, par value $0.001 per shareSEC:0000905718-14-000645:14Canonical exit: 30 Apr 2013 (T+90)
- 59,910 shares@ US$5.49Common Stock, par value $0.001 per shareSEC:0000905718-14-000645:15Canonical exit: 2 May 2013 (T+90)
- 26,000 shares@ US$5.42Common Stock, par value $0.001 per shareSEC:0000905718-14-000645:16Canonical exit: 6 May 2013 (T+90)
- 97,500 shares@ US$5.18Common Stock, par value $0.001 per shareSEC:0000905718-14-000645:17Canonical exit: 9 May 2013 (T+90)
- 5,250 shares@ US$5.25Common Stock, par value $0.001 per shareSEC:0000905718-14-000645:18
- 1,750 shares@ US$5.34Common Stock, par value $0.001 per shareSEC:0000905718-14-000645:19
- 10,000 shares@ US$5.47Common Stock, par value $0.001 per shareSEC:0000905718-14-000645:20
- 4,300 shares@ US$5.98Common Stock, par value $0.001 per shareSEC:0000905718-14-000645:21
- 47,777 shares@ US$5.60Common Stock, par value $0.001 per shareSEC:0000905718-14-000645:22
- 50,678 shares@ US$5.65Common Stock, par value $0.001 per shareSEC:0000905718-14-000645:23
- 19,160 shares@ US$5.71Common Stock, par value $0.001 per shareSEC:0000905718-14-000645:24
25 of 93 declarations
